Clicky

Revolution Medicines, Inc.(RVMD)

Description: Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.


Keywords: Medicine Cancer Clinical Medicine Pharmacology Cancer Treatment Signal Transduction mTOR Combination Therapy Ras Gtpase

Home Page: www.revmed.com

RVMD Technical Analysis

700 Saginaw Drive
Redwood City, CA 94063
United States
Phone: 650 481 6801


Officers

Name Title
Dr. Mark A. Goldsmith Ph.D. CEO, Pres & Chairman
Mr. Jack Anders Chief Financial Officer
Ms. Margaret A. Horn J.D. Chief Operating Officer
Dr. Stephen M. Kelsey FRC Path., FRCP, M.D. Pres of R&D
Ms. Xiaolin Wang Exec. VP of Clinical Devel.
Dr. Martin D. Burke M.D., Ph.D. Co-Founder & Chairman of Scientific Advisory Board
Dr. Michael A. Fischbach Ph.D. Academic Co-Founder & Member of Scientific Advisory Board
Dr. Kevan M. Shokat Ph.D. Academic Co-Founder & Member of Scientific Advisory Board
Mr. David L. Pompliano Ph.D. Founding Chief Scientific Officer
Mr. Walter Reiher Ph.D. Chief Information Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 3.1624
Price-to-Sales TTM: 72.2422
IPO Date: 2020-02-13
Fiscal Year End: December
Full Time Employees: 239
Back to stocks